Organogenesis Holdings Inc.·4

Aug 13, 4:08 PM ET

Grow Brian 4

4 · Organogenesis Holdings Inc. · Filed Aug 13, 2025

Insider Transaction Report

Form 4
Period: 2025-08-11
Grow Brian
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2025-08-11$2.47/sh+4,060$10,028674,550 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-08-114,0600 total
    Exercise: $2.47Exp: 2025-08-11Class A Common Stock (4,060 underlying)
  • Tax Payment

    Class A Common Stock

    2025-08-11$4.62/sh2,173$10,028672,377 total
Footnotes (1)
  • [F1]100% of the shares subject to the option are fully vested and exercisable.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES